NasdaqCM - Nasdaq Real Time Price USD
Immuron Limited (IMRN)
1.6900
-0.0101
(-0.59%)
At close: June 9 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jan 1970) | Next Qtr. (Jan 1970) | Current Year (2025) | Next Year (1970) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IMRN | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Initiated | Litchfield Hills: Buy | 9/26/2024 |
| Initiated | HC Wainwright & Co.: Buy | 10/18/2017 |
Related Tickers
NLSP NLS Pharmaceutics AG
2.7500
+19.57%
GLTO Galecto, Inc.
3.2900
0.00%
KZR Kezar Life Sciences, Inc.
4.4500
+1.14%
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2230
+0.25%
EDSA Edesa Biotech, Inc.
1.9600
+7.10%
HOTH Hoth Therapeutics, Inc.
1.1900
-8.46%
NXTC NextCure, Inc.
0.5285
+6.70%
VTVT vTv Therapeutics Inc.
16.61
+1.82%
XBIO Xenetic Biosciences, Inc.
3.1450
+6.38%
SABS SAB Biotherapeutics, Inc.
1.8600
+3.33%